What medical and pharmaceutical/bioscience/medical device meeting planners and continuing medical education professionals need to know to plan meetings and CME activities for healthcare professionals.
I’ve been thinking a lot lately about what constitutes a challenge, and why it’s important to listen when challenges come calling. I was cogitating especially heavily on the topic recently as I white-knuckled the guy-wires at the top of the SkyJ...
The long-awaited final version of the FDA’s opioid risk evaluation and mitigation strategy includes an educational “blueprint,” new opportunities for continuing medical education providers.
Massachusetts has passed revisions to its Pharmaceutical and Medical Device Manufacturer Code of Conduct that ease some of its restrictions, including the ban on providing meals at non-CME events.
What do you know now that you wish you knew the first time you went through the Accreditation Council for CME's accreditation process? I'm looking to collect some tips for an article in an upcoming issue of Medical Meetings. Please leave a comment...
